Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 May 15;284(6327):1425–1426. doi: 10.1136/bmj.284.6327.1425

Oral anticoagulants reassessed.

L Poller
PMCID: PMC1498331  PMID: 6805548

Full text

PDF
1425

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Duxbury B. M. Therapeutic control of anticoagulant treatment. Br Med J (Clin Res Ed) 1982 Mar 6;284(6317):702–704. doi: 10.1136/bmj.284.6317.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Forfar J. C. A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment. Br Heart J. 1979 Aug;42(2):128–132. doi: 10.1136/hrt.42.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HILDEN T., IVERSEN K., RAASCHOU F., SCHWARTZ M. Anticoagulants in acute myocardial infarction. Lancet. 1961 Aug 12;2(7198):327–331. doi: 10.1016/s0140-6736(61)90629-8. [DOI] [PubMed] [Google Scholar]
  4. Hirsh J. Hypercoagulability. Semin Hematol. 1977 Oct;14(4):409–425. [PubMed] [Google Scholar]
  5. Hull R., Delmore T., Carter C., Hirsh J., Genton E., Gent M., Turpie G., McLaughlin D. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med. 1982 Jan 28;306(4):189–194. doi: 10.1056/NEJM198201283060401. [DOI] [PubMed] [Google Scholar]
  6. Hull R., Delmore T., Genton E., Hirsh J., Gent M., Sackett D., McLoughlin D., Armstrong P. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med. 1979 Oct 18;301(16):855–858. doi: 10.1056/NEJM197910183011602. [DOI] [PubMed] [Google Scholar]
  7. Latallo Z. S., Thomson J. M., Poller L. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy. Br J Haematol. 1981 Feb;47(2):307–318. doi: 10.1111/j.1365-2141.1981.tb02791.x. [DOI] [PubMed] [Google Scholar]
  8. Mitchell J. R. Anticoagulants in coronary heart disease--retrospect and prospect. Lancet. 1981 Jan 31;1(8214):257–262. doi: 10.1016/s0140-6736(81)92095-x. [DOI] [PubMed] [Google Scholar]
  9. Poller L., Thomson J. M., Yee K. F. Quality control trials of prothrombin time: an assessment of the performance in serial studies. J Clin Pathol. 1979 Mar;32(3):251–253. doi: 10.1136/jcp.32.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Taberner D. A., Poller L., Burslem R. W., Jones J. B. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J. 1978 Feb 4;1(6108):272–274. doi: 10.1136/bmj.1.6108.272. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES